Overview
LQDA market data
Price History
LQDA price chart · 1M
- O
- 68.10
- H
- 69.47
- L
- 67.83
- C
- 68.65
- Vol
- 47,168.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $68.10
- Previous Close
- $68.61
- Day High
- $69.47
- Day Low
- $67.83
- 52 Week High
- $93.50
- 52 Week Low
- $39.95
- 7 Day Return
- +1.55%
- 30 Day Return
- -23.08%
- 90 Day Return
- +7.41%
- 1 Year Return
- +29.31%
- Daily Notional Volume
- $3.2M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 44.34 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.80 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.41 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 30.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $21.15 – $93.61 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $6.1B · P/B 12.93 · P/S 13.63.
Company News
10 captured
8-K filing — Liquidia Corp (LQDA)SEC EDGAR ·
Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?Zacks Investment Research ·
Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?Zacks Investment Research ·
Why Liquidia Stock Was Diving This WeekThe Motley Fool ·